Measurement of intestinal permeability using lactulose and mannitol test
Not Applicable
Recruiting
- Conditions
- gastrointestinal disease
- Registration Number
- JPRN-UMIN000043247
- Lead Sponsor
- Asahikawa Medical University Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 750
Inclusion Criteria
Not provided
Exclusion Criteria
1. Presence of galactosemia 2. Presence of an allergy to food containing sugar alcohol 3.Diabetic patients with poor glycemic control 4.Patients who do not consent to participate in this study 5. Determined ineligible by the principal investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie lactulose and mannitol-induced changes in intestinal permeability for gastrointestinal disease?
How does the lactulose/mannitol test compare to other methods in assessing intestinal permeability in patients with inflammatory bowel disease?
What biomarkers correlate with lactulose and mannitol test outcomes in gastrointestinal disease populations?
What are the potential adverse events associated with lactulose and mannitol testing in large-scale clinical studies?
Are there combination therapies or alternative compounds that enhance intestinal barrier function assessment alongside lactulose/mannitol tests?